“…The increased expression of inflammatory cytokines leads to the recruitment of neurotoxic blood-derived iMϕs (CCL2), the resistance to subretinal MP clearance (IL-6), and photoreceptor toxicity (IL-1β) in Cx3cr1-deficient mice (see 4., 5.2.2.3, and 5.2.2.1. respectively) (Eandi et al, 2016;Hu et al, 2015;Sennlaub et al, 2013). Cx3cr1 deletion also increases MP accumulation and associated degenerative changes in other retinal disease models, such as diabetes (Beli et al, 2016;Cardona et al, 2015;Kezic et al, 2013;Mendiola et al, 2016), retinitis pigmentosa (Peng et al, 2014;Zabel and Kirsch, 2013),…”